Policy & Research

Documents & Research

Published briefs, research findings, and policy frameworks supporting the foundation's mission and informing federal healthcare AI strategy.

Document Library

NHAIEF Foundation Concept Overview

Executive Summary

Comprehensive overview of the National Healthcare AI Enablement Foundation, including mission, solution architecture, governance framework, and pilot deployment strategy.

2026

Florida & Texas Pilot Program Brief

Policy Brief

Detailed rationale for dual-state pilot selection, including Medicare population analysis, provider landscape assessment, and evaluation framework.

2026

AI Foundation Model Architecture

Technical Brief

Technical overview of the public-interest foundation model approach, including training data sources, model capabilities, and integration architecture.

Coming Soon

Governance & Ethics Framework

Policy Framework

Comprehensive governance structure including ethics board charter, data privacy framework, conflict of interest policies, and transparency standards.

Coming Soon

Research Areas

Administrative Cost Reduction

Quantifying the impact of AI-driven automation on prior authorization, claims processing, and revenue cycle management across safety-net hospitals.

Workforce Optimization Modeling

Predictive staffing models and burnout detection algorithms designed to reduce contract labor reliance in high-Medicare-mix facilities.

Utilization Variance Analysis

AI-driven identification of avoidable admissions, duplicate testing, and care pathway inefficiencies contributing to per-beneficiary cost growth.

Medicare Cost Impact Modeling

Econometric modeling of projected Medicare savings from foundation model deployment, informing payment stabilization policy.

Strategic Self-Assessment

Pressure Test: Does This Idea Hold Up?

Any organization asking health systems to trust them with AI implementation should be willing to pressure-test their own assumptions with the same rigor they apply to others. The following is a candid analysis of NHAIEF's core thesis — its foundational assumption, its most serious risks, and the specific profile of health system it is built to serve.

This analysis follows a structured startup evaluation methodology adapted from early-stage venture validation frameworks. It is intended to build trust through transparency, not to serve as legal or financial disclosure.

Core Assumption

Health systems — particularly safety-net and rural hospitals — will adopt AI faster, more safely, and with better outcomes when a trusted, vendor-neutral, federally-aligned non-profit intermediary coordinates selection, validation, and implementation — versus navigating the commercial vendor market alone.

This assumption is testable before full deployment. If pilot site health systems report that they would have made the same AI adoption decisions without NHAIEF's involvement, the model fails. Pilot evaluation is specifically designed to measure this.

Three Most Serious Risks — Ranked by Severity

1

No federal authorization or appropriation — yet

Highest Risk

The label 'federally aligned' currently reflects strategic positioning, not statutory authority or confirmed federal funding. Health system CFOs and boards will not commit pilots without that certainty. If NHAIEF cannot secure a formal CMS relationship, CMMI engagement, or Congressional appropriation in Year 1, the credibility gap widens faster than the mission can overcome it.

Mitigation Strategy

The pilot launch strategy is explicitly sequenced to establish CMS/CMMI dialogue before health system recruitment begins. The three-year milestone plan treats federal authorization as a Year 1 deliverable, not an aspiration.

2

EHR vendor lock-in is structural — not solved by an intermediary

High Risk

Epic, Oracle/Cerner, and Optum have contractual and technical control over data access in the majority of target health systems. Any AI model NHAIEF validates must ultimately integrate through these vendors' platforms and marketplaces. A 'vendor-neutral' endorsement may be neutralized if the path to deployment still runs through commercial vendor channels.

Mitigation Strategy

NHAIEF's interoperability certification program is specifically designed to test integration with major EHR platforms, and the advisory structure includes health system IT leadership. Engagement with EHR vendors is treated as partnership management, not a point of differentiation.

3

Validation certification has no current regulatory weight

Moderate Risk

Without FDA or CMS authority backing its validation certifications, an 'NHAIEF-approved' designation has no binding value in procurement or reimbursement contexts. Health systems will not prioritize a validated model over an existing vendor relationship unless the certification carries downstream consequences — financial, legal, or regulatory.

Mitigation Strategy

The Medicare Innovation Lab is designed to generate the evidence base needed for CMS to eventually reference NHAIEF validation standards in value-based care program requirements. This is a multi-year strategy, not a launch condition.

Problem Validation: Vitamin or Painkiller?

Administrative burden is documented, quantified, and a top CEO priority — the pain is real. But "AI vendor selection paralysis" manifests differently depending on the health system.

Painkiller

Safety-Net & Rural Systems

No internal AI expertise. No budget margin for implementation failure. Cannot afford a vendor mistake. NHAIEF is the difference between adopting AI and not adopting it at all. The intermediary solves an otherwise unsolvable access problem.

Strong Vitamin

Mid-Size Regional Systems

Some internal IT capacity but limited AI governance expertise. Value is high — particularly for fellowship programs and validation access — but self-service adoption is possible without NHAIEF involvement.

Vitamin

Large Academic Medical Centers

Internal AI research and implementation capacity exists. NHAIEF's value shifts to co-investigator relationships, policy influence, and Medicare Innovation Lab outputs rather than direct deployment support.

Early Adopter Profile

The health system most likely to engage first — and produce the strongest evidence — looks like this:

COO or CFO at a 200–400 bed DSH-designated hospital in Florida or Texas

Medicare/Medicaid mix above 55%; operating margin under 3%

Currently under CMS quality reporting or readmission penalty pressure

Has expressed public interest in AI adoption but taken no definitive action

Previously received HRSA, CMS improvement, or state innovation grant funding

No internal data science or AI governance staff

5 Customer Discovery Questions

Questions used with prospective pilot sites to validate whether the problem is real and urgent.

  1. 1.

    "Walk me through the last time you evaluated an AI vendor — what happened, and what did you decide?"

  2. 2.

    "What would have to be true about an AI solution for you to feel comfortable presenting it to your board?"

  3. 3.

    "If NHAIEF didn't exist, how would you solve the 'which AI vendor should I trust' problem?"

  4. 4.

    "What's the most expensive operational problem you're not solving because you don't trust the available solutions?"

  5. 5.

    "What would it mean for your organization if you got this wrong — if you picked an AI tool that didn't perform?"

Honest Verdict

The idea is structurally sound. The execution risk is high and front-loaded.

NHAIEF solves a genuine, documented, and urgent problem for safety-net and rural health systems. The intermediary model has historical federal precedent (RECs, CMMI, AHRQ). The four-pillar accelerator design is internally coherent and addresses the right gaps in the ecosystem.

The highest-risk assumption is not the mission — it's the sequencing. Federal authorization must come before health system recruitment. A validated safety-net partner must come before a broader rollout. If that sequencing holds, the model is fundable, scalable, and policy-relevant. If it breaks — if federal engagement is slow and early health systems disengage — the window for establishing credibility closes quickly.

Landscape & Positioning

Healthcare AI Ecosystem

Several organizations operate in the healthcare AI space, spanning federal agencies, nonprofits, and private-sector platforms. While each contributes valuable capabilities, no single entity currently integrates all four functions of a national AI adoption accelerator.

The representative landscape below maps existing players against the four capabilities central to NHAIEF's accelerator model: workforce development, deployment funding, independent model validation, and Medicare-specific policy evidence.

Federal & Government-Adjacent

CMS Innovation Center (CMMI)

Payment model experiments and demonstration projects

Gap

Primarily focused on payment reform; not typically organized as an AI deployment accelerator

ONC (Office of the National Coordinator)

Health IT standards, interoperability, and certification

Gap

Centered on data standards and interoperability rather than AI-specific adoption infrastructure

AHRQ

Health services research funding and evidence synthesis

Gap

Research and evidence synthesis focus; limited operational deployment or workforce programs

NIH / NLM

Biomedical AI research and dataset curation

Gap

Oriented toward basic and translational research rather than health system-level deployment

Nonprofits & Think Tanks

Coalition for Health AI (CHAI)

Developing consensus guidelines for responsible health AI deployment

Gap

Primarily standards and guidelines; not structured as a deployment accelerator with funding or fellowships

Duke-Margolis Center for Health Policy

Healthcare AI policy research and convening

Gap

Policy analysis and convening focus; not designed for operational deployment or workforce training

Brookings / RAND

Healthcare AI policy analysis and publications

Gap

Research and publishing orientation; not structured to operate deployment programs

AMA / AHA

Professional guidance on AI adoption for members

Gap

Member-facing guidance and advocacy; not organized around independent model validation or pilot grants

Private Sector & Health Systems

Health System Consortiums (Mayo, Mass General Brigham)

Deploying AI within their own networks and research programs

Gap

Primarily serve their own networks; not structured as public-interest infrastructure for safety-net or rural systems

EHR & Technology Vendors (Epic, Google Health, Nuance)

Commercial AI products embedded in clinical and administrative workflows

Gap

Commercial orientation; not designed for neutral, independent validation or Medicare-specific cost reform

NHAIEF Differentiation

No single organization currently combines all four capabilities in an integrated, public-interest accelerator model. NHAIEF is designed to fill this structural gap.

Fellowship Programs

Integrated

Structured healthcare AI fellowship tracks for clinicians, administrators, and governance professionals are not typically available through existing accelerator models.

Pilot Funding

Integrated

Direct deployment grants targeting safety-net and rural health systems are not broadly available through current nonprofit or federal AI infrastructure programs.

Model Validation Sandbox

Integrated

Independent, public-interest AI model validation is not widely available outside proprietary vendor ecosystems or individual health system programs.

Medicare Innovation Lab

Integrated

Dedicated cost-impact evidence production designed specifically to inform CMS AI policy and Medicare reform is not a primary function of existing entities.

Positioning Note

NHAIEF is positioned between federal agencies and private vendors, combining the public accountability of government-aligned infrastructure with the operational agility of a focused accelerator. The model is designed to earn credibility through independent validation, attract federal grants through measurable outcomes, and establish public legitimacy through transparent governance and workforce development.

Legislative Context

Federal Precedents for Health Infrastructure Investment

Congress has a demonstrated record of funding public-interest health technology infrastructure. NHAIEF's accelerator model draws on the structural lessons of previous successful programs.

Each precedent below involved federal investment in technology adoption infrastructure that reduced costs, improved quality, and created measurable returns on public spending.

HITECH Act (2009)

$27B+ in EHR incentives

Near-universal EHR adoption across U.S. hospitals, from ~10% to 96% within a decade

Structural Lesson

Federal investment in health technology infrastructure produces rapid, measurable adoption when paired with implementation support and financial incentives.

ONC Data Brief, 2021

Regional Extension Centers (RECs)

$677M across 62 centers

Assisted 140,000+ primary care providers with EHR adoption, particularly in rural and underserved areas

Structural Lesson

Locally embedded technical assistance, modeled as a public-interest support layer, accelerates adoption among providers who lack internal IT capacity.

ONC REC Program Final Report, 2016

CMMI Innovation Models

$10B+ authorized (ACA Section 3021)

Tested 50+ payment and delivery models; several adopted permanently (e.g., Medicare Shared Savings Program)

Structural Lesson

Structured pilot programs with rigorous evaluation produce the evidence base needed for permanent policy reform and appropriations renewal.

CMS Innovation Center Annual Report

AHRQ Health IT Portfolio

$300M+ in health IT research

Established evidence base for clinical decision support, patient safety systems, and interoperability standards

Structural Lesson

Federal research investment in applied health technology produces standards and evidence that accelerate safe deployment system-wide.

AHRQ Health IT Initiative Summary

Appropriations Alignment

NHAIEF's structure is designed to align with existing federal funding mechanisms including CMMI demonstration authority, AHRQ health services research appropriations, NIH/NSF computing infrastructure programs, and potential standalone authorization under healthcare innovation and cost-containment appropriations. The $15M three-year pilot estimate represents a fraction of the demonstrated federal investment in comparable health infrastructure programs.

Research Design

Evaluation Methodology

All pilot outcomes are evaluated using established health services research methodologies designed to produce evidence meeting federal standards for policy decision-making.

The evaluation framework is structured to support both internal program improvement and external reporting to CMS, Congressional committees, and peer-reviewed journals.

Difference-in-Differences

Primary causal identification strategy comparing cost and utilization trends at pilot sites versus matched comparison facilities, controlling for secular trends and regional variation.

Applied To

Medicare cost per beneficiary, administrative cost ratio, readmission rates

Propensity Score Matching

Statistical matching of pilot sites to comparable non-participating systems based on Medicare volume, payer mix, bed count, geographic region, and baseline cost trajectories.

Applied To

Cross-site comparisons, generalizability assessment

Interrupted Time Series

Analysis of outcome trajectories before and after AI deployment at each pilot site, identifying changes in level and trend attributable to the intervention.

Applied To

Site-level cost trends, LOS changes, staffing patterns

Mixed-Methods Process Evaluation

Qualitative interviews, workflow observation, and implementation fidelity assessment documenting how AI tools are adopted, adapted, and sustained within health system operations.

Applied To

Implementation barriers, workflow integration, staff experience

Health Economic Modeling

Microsimulation and actuarial modeling projecting pilot site outcomes to state-level and national-level Medicare cost impact under various scale-up scenarios.

Applied To

Medicare Trust Fund projections, national scale-up estimates

Equity Impact Analysis

Stratified analysis of outcomes by race, ethnicity, geography, and payer status to assess whether AI deployment reduces or exacerbates existing healthcare disparities.

Applied To

Disparate impact detection, equity-adjusted outcomes

Data Access & Research Collaboration

Research Data Framework

NHAIEF is committed to open science principles. The following framework governs data availability, access controls, and publication rights for research collaborators.

Data Availability

De-identified pilot site data including cost, utilization, staffing, and model performance metrics. Raw data available through secure data enclave; summary datasets published as open-access.

Access Tiers

Three-tier model: public summary datasets (open access), researcher-level datasets (DUA required), and site-level granular data (IRB approval + institutional DUA). Access governed by Data Access Committee.

Publication Rights

All research collaborators retain full publication rights. Foundation review limited to 30-day accuracy check period with no editorial control. Pre-registration of studies encouraged through ClinicalTrials.gov or OSF.

IRB & Ethics Review

Multi-site IRB protocol coordinated through a central IRB of record. Individual pilot sites may rely on the central IRB or maintain their own, per institutional preference. Ethics Review Board provides supplementary oversight.

Research Collaboration Note

Academic institutions and independent researchers interested in evaluation partnerships should contact research@nhaieffoundation.org. The foundation welcomes proposals for secondary analysis, replication studies, and independent evaluation of pilot outcomes. Funded evaluation grants (up to $250K) are available through the Pilot Funding program.

News & Updates

Latest Developments

Updates on foundation formation, pilot progress, policy developments, and research findings.

February 2026

Foundation Concept Published

Initial concept document outlining the NHAIEF mission, governance framework, and dual-state pilot strategy for Florida and Texas.

Q1 2026

Advisory Board Formation

Assembly of initial advisory board including health system executives, policy experts, and clinical leaders.

Q2 2026

Pilot Partner Identification

Formal outreach to safety-net hospitals, rural health systems, and high Medicare-mix providers in Florida and Texas.